source
- Cancer drug shortages persist, hampering patient care and highlighting lasting impacts of platinum chemotherapyThe STAT+ newsletter reports that cancer treatment centers continue to struggle with ongoing shortages of key oncology drugs, forcing clinicians to alter or delay therapy for patients. These short…
- Samsung Biologics secures $262 million manufacturing contract with European pharma firmSamsung Biologics announced a $262 million agreement to provide manufacturing services to an unnamed European pharmaceutical company. The contract runs through 2033. The deal will be executed at S…